Sorrento Announces It Has Submitted An Emergency Use Authorization (EUA) Application to the FDA for COVI-STIX™ Rapid Test for the Detection of SARS-CoV-2 Viral Antigen

Go back to Sorrento Announces It Has Submitted An Emergency Use Authorization (EUA) Application to the FDA for COVI-STIX™ Rapid Test for the Detection of SARS-CoV-2 Viral Antigen
SORRENTO THERAPEUT (AMEX: SRNE) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High $10.26 
Open $0.00    52 Week Low $4.25 
Day High $0.00    P/E 0.00 
Day Low $0.00    EPS $-0.50 
Volume 29,020